Connect with us

Berita

Gelar Diklat Integrasi, Kasepolwan Harapkan Wanita TNI-Polri Bersatu Jadi Pemersatu Bangsa

Published

on

Anggota TNI-Polri wanita melaksanakan pendidikan dan pelatihan (diklat) integrasi. Sebanyak 503 peserta dari Polri, TNI AD, TNI AL dan TNI AU mengikuti diklat integrasi yang dibuka oleh Wakapolda Kalimantan Tengah Irjen Ida Oetari Poernamasasi pada Senin kemarin, 12 Desember 2022.

Kepala Sekolah Polwan (Kasepolwan) Lemdiklat Polri, Kombes Pol Ratna Setiawati mengatakan, dari 503 peserta yang mengikuti diklat integrasi, sebanyak 75 peserta berasal dari Kowad, 20 dari Kowal, 20 dari Wara dan sisanya merupakan Polwan angkatan ke-52.

“Diklat integrasi ini kali pertama semuanya lengkap. Pada tahun kemarin diklat integrasi hanya diikuti oleh Angkatan Darat,” kata Ratna di Jakarta, Selasa (13/12/2022).

Dengan lengkapnya Polri dan semua matra TNI mengikuti diklat integrasi ini, ia pun mengatakan bahwa wanita TNI-Polri selalu bersatu mengabdikan diri untuk menjadi pemersatu bangsa dan mempererat demokasi di Indonesia agar NKRI selalu utuh.

“TNI Polri adalah lembaga yang menjadi kekuatan utama bangsa,” ujarnya.

Dalam diklat ini, Ratna mengatakan, peserta akan dikenal doktrin dari kedua belah pihak yaitu dari TNI-Polri. Dari peserta polwan akan dikenalkan bagaimana Sapta Marga saat dulu masih TNI-Polri bersatu dengan nama ABRI. Sementara peserta dari TNI akan diajarkan bagaimana pedoman hidup Polri yaitu Tribrata dan Catur Prasetya.

“Saat ini kita punya lima materi terkait dengan patra, pengenalan doktrin, terkait fungsi tugas pokok tentang perbantuan TNI maupun Polri serta bagaimana membangun sinergritas,” katanya.

Ia pun berharap ke depan diklat integrasi ini secara kualitas dan kuantitas terus bertambah dan lebih baik. Dari segi kualitas, ia berharap akan ditambah dan divariasikan materi-materi lain yang bersifat lebih mengedepankan kebersamaan antara TNI Polri.

“Lalu harapan kami dari segi kuantitas diharapkan dengan adanya diklat integrasi ini akan bertambah jumlah siswa Dikmaba baik dari Kowad, Kowal dan Wara yang saat ini hanya 20 peserta,” katanya.

Continue Reading
Click to comment

Leave a Reply

Alamat email Anda tidak akan dipublikasikan. Ruas yang wajib ditandai *

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

tc-check-test1

Published

on

tc-manager precheck test1 – https://test1.com

Continue Reading

Trending